No Photo Available

Last Update

2016-12-16T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Peter Mueller?

Dr. Peter R. Mueller

Chief Scientific Officer and Executive Vice President of Global Research and Development

Vertex Pharmaceuticals Incorporated

Direct Phone: (617) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston, Massachusetts 02210

United States

Company Description

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has m ... more

Find other employees at this company (3,018)

Background Information

Employment History

Senior Vice President, Research and Development

Boehringer Ingelheim Corporation

President of Research and Development and CSO

Axcella Health Inc

President of Research and Development and CSO

Pronutria Biosciences Inc

President

Epicenter Consulting LLC

Chief Operating Officer

Amarillo Biosciences , Inc.

Vice President, Global Marketing and Medical Information and Technology

Aventis SA

Director of Global Commercial Development

Merrell Dow

Affiliations

Advisory Board Member
USA India Chamber of commerce

Board Member
Inhibikase Therapeutics Inc

Board Member
Gesellschaft Deutscher Chemiker

Member of Council On Economic Competitiveness and Technology for the State of Connecticut
Govenor Roland

Advisory Board Member
Phacilitate Limited

Scientific Advisory Board Member
Keystone Symposia

Advisory Board Member
Biosensor Forum

Delegate
GDS International Ltd

Faculty Member
Albert Einstein University of Ulm , Germany

Member
American Association for the Advancement of Science

Member
Royal Society of Chemistry

Member
The RNA Society

Education

MBA

Babson

Ph.D.

Pharmacology

University of Mainz

PhD

Chemistry

Albert Einstein University of Ulm , Germany

undergraduate degree

Albert Einstein University of Ulm , Germany

Web References (131 Total References)


USA India Chamber of commerce - Delivering Affordable Innovation through Global Partnerships

www.usaindiachamber.org [cached]

Dr. Peter Mueller President R&D and CSO


Board of Directors | Inhibikase Therapeutics, Inc.

www.inhibikase.com [cached]

Peter Mueller, PhD.

Dr. Mueller joined Vertex in July 2003. As Executive Vice President Global Research and Development & Chief Scientific Officer, he provides strategic oversight for Vertex's worldwide drug discovery research programs, Pharmaceutical Development, Quality Assurance and Control, Pharmaceutical Operations as well as Clinical and Non-Clinical Development, Regulatory, Patient Safety and Medical Affairs. Key areas of Vertex' R&D are Hepatitis C, Cystic Fibrosis, IMID, Cancer, and Neurological Diseases which led in 2011 to the successful approval and launch of INCIVEK (HepC), a NDA/MAA submission for KALYDECO (CF) with the first approval in the US in January 2012 and several proof of clinical concept candidates in various disease areas. Prior to coming to Vertex, Dr. Mueller served as Senior Vice President, Research and Development, for Boehringer Ingelheim Pharmaceuticals, Inc. where he was responsible for the development of all drug candidates of the company's worldwide portfolio in North and South America, Canada and Japan, beginning in 1997. He also led research programs in the areas of immunology, inflammation, cardiovascular disease and gene therapy on a global basis. During his time with Boehringer Ingelheim, Dr. Mueller oversaw the discovery of numerous development candidates, held several positions in basic research, medicinal chemistry and management in different centers of BI worldwide.
Dr. Mueller received both an undergraduate degree and a Ph.D. in Chemistry at the Albert Einstein University of Ulm, Germany, where he also holds a Professorship in Theoretical Organic Chemistry. He completed fellowships in Quantum Pharmacology at Oxford University and in Biophysics at Rochester University.


Health Industry Updates

www.leadershipdirectories.com [cached]

Vertex Pharmaceuticals Incorporated announced that Peter Mueller will retire as Executive Vice President of Global Research and Development and Chief Scientific Officer, effective October 31, 2014.


"Kalydeco is an exciting new ...

www.ispeboston.org [cached]

"Kalydeco is an exciting new beginning in the treatment of cystic fibrosis, but we're not finished," said Peter Mueller, Ph.D., Chief Scientific Officer and Executive Vice President of Global Research and Development at Vertex.


Dr. Peter ...

www.usaindiachamber.org [cached]

Dr. Peter Mueller Executive Vice President Global R&D & CSO Vertex Pharmaceuticals

Similar Profiles

Other People with this Name

Other people with the name Mueller

Gregor Mueller
ISOVOLTA GATEX GmbH

Markus Mueller
University of Western Ontario

Elisa Mueller
Kempinski

Robert Mueller
Okotoks Flowers & Things

Jessica Mueller
University of Missouri

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory